Skip to main content
. 2013 Jun 27;8(6):e67481. doi: 10.1371/journal.pone.0067481

Table 3. Clinical characteristics of patients with viral resistance.

Patient Ethnicity HBeAg status HBV-genotype Treatment regimen Duration of minimal residual viremia until viral resistance (months) Serum samples with minimal residual viremia (n) Viral mutation HBV-DNA (IU/mL) at time of resistance
Patient 1 Caucasian Negative D ADV 45 7/7 A181V, 81200
(100%) N236X
Patient 2 Caucasian Positive A ADV 21 4/4 N236T 71600
(100%)
Patient 3 Caucasian Negative A LAM 31 5/5 M204I 4240
(100%)